| pubmed-article:11812089 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11812089 | lifeskim:mentions | umls-concept:C0302592 | lld:lifeskim |
| pubmed-article:11812089 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11812089 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:11812089 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:11812089 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:11812089 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
| pubmed-article:11812089 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
| pubmed-article:11812089 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:11812089 | pubmed:dateCreated | 2002-1-28 | lld:pubmed |
| pubmed-article:11812089 | pubmed:abstractText | The purpose of this study was to determine whether positron emission tomography (PET) using F-18-fluorodeoxyglucose (FDG) before and after radiotherapy would predict whether local control of cervical cancer had been achieved. | lld:pubmed |
| pubmed-article:11812089 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11812089 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11812089 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11812089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11812089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11812089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11812089 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11812089 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:11812089 | pubmed:issn | 0090-8258 | lld:pubmed |
| pubmed-article:11812089 | pubmed:author | pubmed-author:EisbruchAvrah... | lld:pubmed |
| pubmed-article:11812089 | pubmed:author | pubmed-author:NakamotoYujiY | lld:pubmed |
| pubmed-article:11812089 | pubmed:author | pubmed-author:AchtyesEric... | lld:pubmed |
| pubmed-article:11812089 | pubmed:author | pubmed-author:SugawaraYoshi... | lld:pubmed |
| pubmed-article:11812089 | pubmed:author | pubmed-author:ReynoldsKevin... | lld:pubmed |
| pubmed-article:11812089 | pubmed:author | pubmed-author:JohnstonCarol... | lld:pubmed |
| pubmed-article:11812089 | pubmed:author | pubmed-author:WahlRichard... | lld:pubmed |
| pubmed-article:11812089 | pubmed:copyrightInfo | ©2002 Elsevier Science. | lld:pubmed |
| pubmed-article:11812089 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11812089 | pubmed:volume | 84 | lld:pubmed |
| pubmed-article:11812089 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11812089 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11812089 | pubmed:pagination | 289-95 | lld:pubmed |
| pubmed-article:11812089 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
| pubmed-article:11812089 | pubmed:meshHeading | pubmed-meshheading:11812089... | lld:pubmed |
| pubmed-article:11812089 | pubmed:meshHeading | pubmed-meshheading:11812089... | lld:pubmed |
| pubmed-article:11812089 | pubmed:meshHeading | pubmed-meshheading:11812089... | lld:pubmed |
| pubmed-article:11812089 | pubmed:meshHeading | pubmed-meshheading:11812089... | lld:pubmed |
| pubmed-article:11812089 | pubmed:meshHeading | pubmed-meshheading:11812089... | lld:pubmed |
| pubmed-article:11812089 | pubmed:meshHeading | pubmed-meshheading:11812089... | lld:pubmed |
| pubmed-article:11812089 | pubmed:meshHeading | pubmed-meshheading:11812089... | lld:pubmed |
| pubmed-article:11812089 | pubmed:meshHeading | pubmed-meshheading:11812089... | lld:pubmed |
| pubmed-article:11812089 | pubmed:meshHeading | pubmed-meshheading:11812089... | lld:pubmed |
| pubmed-article:11812089 | pubmed:meshHeading | pubmed-meshheading:11812089... | lld:pubmed |
| pubmed-article:11812089 | pubmed:meshHeading | pubmed-meshheading:11812089... | lld:pubmed |
| pubmed-article:11812089 | pubmed:meshHeading | pubmed-meshheading:11812089... | lld:pubmed |
| pubmed-article:11812089 | pubmed:meshHeading | pubmed-meshheading:11812089... | lld:pubmed |
| pubmed-article:11812089 | pubmed:meshHeading | pubmed-meshheading:11812089... | lld:pubmed |
| pubmed-article:11812089 | pubmed:meshHeading | pubmed-meshheading:11812089... | lld:pubmed |
| pubmed-article:11812089 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11812089 | pubmed:articleTitle | Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy. | lld:pubmed |
| pubmed-article:11812089 | pubmed:affiliation | Division of Nuclear Medicine, Johns Hopkins University, Baltimore, Maryland 21287-0817, USA. | lld:pubmed |
| pubmed-article:11812089 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11812089 | pubmed:publicationType | Clinical Trial | lld:pubmed |
